{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T09:17:01Z","timestamp":1775985421257,"version":"3.50.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.jneuroim.2008.06.020","type":"journal-article","created":{"date-parts":[[2008,7,30]],"date-time":"2008-07-30T04:32:45Z","timestamp":1217392365000},"page":"95-103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Towards antigen-specific apheresis of pathogenic autoantibodies as a further step in the treatment of myasthenia gravis by plasmapheresis"],"prefix":"10.1016","volume":"201-202","author":[{"given":"Paraskevi","family":"Zisimopoulou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Lagoumintzis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kalliopi","family":"Kostelidou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kalliopi","family":"Bitzopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory","family":"Kordas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos","family":"Trakas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Poulas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Socrates J.","family":"Tzartos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2008.06.020_bib1","series-title":"Current Clinical Neurology: Myasthenia Gravis and Related Disorders","first-page":"177","article-title":"Specific antibodies in the diagnosis and management of autoimmune disorders of neuromuscular transmission and related diseases","author":"Agius","year":"2003"},{"key":"10.1016\/j.jneuroim.2008.06.020_bib2","first-page":"247","article-title":"Nicotinic acetylcholine receptors in ganglionic transmission","volume":"vol. 144","author":"Berg","year":"2000"},{"key":"10.1016\/j.jneuroim.2008.06.020_bib3","unstructured":"Bitzopoulou, K., Kostelidou, K., Poulas, K., Tzartos, S.J., submitted for publication. Mutant forms of the extracellular domain of the human acetylcholine receptor-subunit with improved solubility and enhanced antigenicity. The importance of the Cys-loop. BBA."},{"key":"10.1016\/j.jneuroim.2008.06.020_bib4","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1212\/WNL.47.3.674","article-title":"Complications of intravenous immune globulin treatment in neurologic disease","volume":"47","author":"Brannagan","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2008.06.020_bib5","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/35077011","article-title":"Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors","volume":"411","author":"Brejc","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2008.06.020_bib6","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1046\/j.1526-0968.2000.004004291.x","article-title":"The six year experience of plasmapheresis in patients with myasthenia gravis","volume":"4","author":"Chiu","year":"2000","journal-title":"Therap. Apher."},{"key":"10.1016\/j.jneuroim.2008.06.020_bib7","article-title":"Autoimmune neuromuscular transmission disorders: myasthenia gravis and Lambert-Eaton myasthenic syndrome","volume":"7","author":"Conti-Fine","year":"2001","journal-title":"Continuum"},{"key":"10.1016\/j.jneuroim.2008.06.020_bib8","series-title":"Neuromuscular Disorders in Clinical Practice","first-page":"364","article-title":"Immunotherapies in the treatment of neuromuscular disorders","author":"Dalakas","year":"2002"},{"key":"10.1016\/j.jneuroim.2008.06.020_bib9","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1056\/NEJM197711242972102","article-title":"Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis","volume":"297","author":"Dau","year":"1977","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2008.06.020_bib10","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/ana.410110603","article-title":"A newly recognized congenital myasthenic syndrome attributed to a prolonged open time of the acetylcholine-induced ion channel","volume":"11","author":"Engel","year":"1982","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2008.06.020_bib11","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1749-6632.1993.tb22941.x","article-title":"Therapies for exacerbation of myasthenia gravis. The mechanism of action of intravenous high-dose immunoglobulin G","volume":"681","author":"Ferrero","year":"1993","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2008.06.020_bib12","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2217\/14796708.1.6.799","article-title":"Recent advances in the understanding and therapy of myasthenia gravis","volume":"1","author":"Fostieri","year":"2006","journal-title":"Future Neurol."},{"key":"10.1016\/j.jneuroim.2008.06.020_bib13","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/j.1749-6632.1987.tb51387.x","article-title":"High-dose intravenous gamma globulin for myasthenia gravis: an alternative to plasma exchange","volume":"505","author":"Gajdos","year":"1987","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2008.06.020_bib14","first-page":"262","article-title":"The keratinocyte cholinergic system with acetylcholine as an epidermal cytotransmitter","volume":"4","author":"Grando","year":"1997","journal-title":"Curr. Opin. Dermatol."},{"key":"10.1016\/j.jneuroim.2008.06.020_bib15","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jim.2005.04.013","article-title":"Preparation of an immunoadsorbent coupled with a recombinant antigen to remove anti-acetylcholine receptor antibodies in abnormal serum","volume":"303","author":"Guo","year":"2005","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jneuroim.2008.06.020_bib16","first-page":"193","article-title":"Presynaptic neuronal nicotinic receptors: pharmacology, heterogeneity and cellular mechanisms","volume":"vol. 144","author":"Kaiser","year":"2000"},{"key":"10.1016\/j.jneuroim.2008.06.020_bib17","series-title":"Neuromuscular Disorders in Clinical Practice","first-page":"916","article-title":"Myasthenia gravis","author":"Kaminski","year":"2001"},{"key":"10.1016\/j.jneuroim.2008.06.020_bib18","series-title":"Current Clinical Neurology: Myasthenia Gravis and Related Disorders","first-page":"197","article-title":"Treatment of myasthenia gravis","author":"Kaminski","year":"2003"},{"key":"10.1016\/j.jneuroim.2008.06.020_bib19","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nrn731","article-title":"Emerging structure of the nicotinic acetylcholine receptors","volume":"3","author":"Karlin","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.jneuroim.2008.06.020_bib20","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1056\/NEJMra993360","article-title":"Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin","volume":"345","author":"Kazatchkine","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2008.06.020_bib21","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.1111\/j.1742-4658.2006.05363.x","article-title":"Expression and characterization of soluble forms of the extracellular domains of the beta, gamma and epsilon subunits of the human muscle acetylcholine receptor","volume":"273","author":"Kostelidou","year":"2006","journal-title":"FEBS J."},{"key":"10.1016\/j.jneuroim.2008.06.020_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2007.07.018","article-title":"Extracellular domains of the beta, gamma and epsilon subunits of the human acetylcholine receptor as immunoadsorbents for myasthenic autoantibodies: a combination of immunoadsorbents results in increased efficiency","author":"Kostelidou","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2008.06.020_bib23","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1113\/jphysiol.1983.sp014943","article-title":"Antibodies to motor nerve terminals: an electrophysiological study of a human myasthenic syndrome transferred to mouse","volume":"344","author":"Lang","year":"1983","journal-title":"J. Physiol."},{"key":"10.1016\/j.jneuroim.2008.06.020_bib24","first-page":"101","article-title":"The structures of neuronal nicotinic receptors","volume":"vol. 144","author":"Lindstrom","year":"2000"},{"key":"10.1016\/j.jneuroim.2008.06.020_bib25","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1212\/WNL.26.11.1054","article-title":"Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value","volume":"26","author":"Lindstrom","year":"1976","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2008.06.020_bib26","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/mus.880010206","article-title":"Specificities of antibodies to acetylcholine receptors","volume":"1","author":"Lindstrom","year":"1978","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2008.06.020_bib27","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1002\/eji.1830221129","article-title":"Use of Torpedo-mouse hybrid acetylcholine receptors reveals immunodominance of the alpha subunit in myasthenia gravis antisera","volume":"22","author":"Loutrari","year":"1992","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jneuroim.2008.06.020_bib28","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0022-3565(24)37807-3","article-title":"Human vascular endothelial cells express functional nicotinic acetylcholine receptors","volume":"287","author":"Macklin","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jneuroim.2008.06.020_bib29","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/039139880102400102","article-title":"Selective apheresis\u2014time for a change","volume":"24","author":"Mat ic","year":"2001","journal-title":"Int. J. Artif. Organs"},{"key":"10.1016\/j.jneuroim.2008.06.020_bib30","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1124\/mol.54.5.779","article-title":"Human and rodent bronchial epithelial cells express functional nicotinic acetylcholine receptors","volume":"54","author":"Maus","year":"1998","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jneuroim.2008.06.020_bib31","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0022-510X(88)90170-0","article-title":"Passive transfer of myasthenia gravis by immunoglobulins: lack of correlation between AChR with antibody bound, acetylcholine receptor loss and transmission defect","volume":"84","author":"Mossman","year":"1988","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2008.06.020_bib32","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1126\/science.180.4088.871","article-title":"Autoimmune response to acetylcholine receptor","volume":"180","author":"Patrick","year":"1973","journal-title":"Science"},{"key":"10.1016\/j.jneuroim.2008.06.020_bib33","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0140-6736(76)91917-6","article-title":"Remission of myasthenia gravis following plasma-exchange","volume":"2","author":"Pinching","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2008.06.020_bib34","doi-asserted-by":"crossref","first-page":"26980","DOI":"10.1074\/jbc.M110731200","article-title":"Expression of soluble ligand- and antibody-binding extracellular domain of human muscle acetylcholine receptor alpha subunit in yeast Pichia pastoris. Role of glycosylation in alpha-bungarotoxin binding","volume":"277","author":"Psaridi-Linardaki","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jneuroim.2008.06.020_bib35","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1196\/annals.1254.071","article-title":"Future therapeutic strategies in autoimmune myasthenia gravis","volume":"998","author":"Psaridi-Linardaki","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2008.06.020_bib36","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jneuroim.2004.10.002","article-title":"Specific immunoadsorption of the autoantibodies from myasthenic patients using the extracellular domain of the human muscle acetylcholine receptor alpha-subunit. Development of an antigen-specific therapeutic strategy","volume":"159","author":"Psaridi-Linardaki","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2008.06.020_bib37","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.transci.2003.11.005","article-title":"Changes of plasma proteins after immunoadsorption using Ig-Adsopak columns in patients with myasthenia gravis","volume":"30","author":"Ptak","year":"2004","journal-title":"Transfus. Apher. Sci."},{"key":"10.1016\/j.jneuroim.2008.06.020_bib38","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1126\/science.291.5503.484","article-title":"Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor","volume":"291","author":"Samuelsson","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.jneuroim.2008.06.020_bib39","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1172\/JCI5232","article-title":"Prenatal nicotine increases pulmonary alpha7 nicotinic receptor expression and alters fetal lung development in monkeys","volume":"103","author":"Sekhon","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2008.06.020_bib40","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/ana.410380505","article-title":"Acquired neuromyotonia: evidence for autoantibodies directed against K+ channels of peripheral nerves","volume":"38","author":"Shillito","year":"1995","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2008.06.020_bib41","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jneuroim.2007.06.014","article-title":"Isolation and functional characterization of anti-acetylcholine receptor subunit-specific autoantibodies from myasthenic patients: receptor loss in cell culture","volume":"189","author":"Sideris","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2008.06.020_bib42","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ejphar.2005.05.011","article-title":"Nicotinic receptors regulate B lymphocyte activation and immune response","volume":"517","author":"Skok","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jneuroim.2008.06.020_bib43","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1046\/j.1526-0968.2001.00367.x","article-title":"Immunoadsorption in myasthenia gravis based on specific ligands mimicking the immunogenic sites of the acetylcholine receptor","volume":"5","author":"Takamori","year":"2001","journal-title":"Therap. Apher."},{"key":"10.1016\/j.jneuroim.2008.06.020_bib44","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0165-5728(87)90092-0","article-title":"Passive transfer of experimental autoimmune myasthenia gravis by monoclonal antibodies to the main immunogenic region of the acetylcholine receptor","volume":"15","author":"Tzartos","year":"1987","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2008.06.020_bib45","article-title":"Antigen-specific apheresis of pathogenic autoantibodies from myasthenia gravis sera. Antigen-specific apheresis of pathogenic autoantibodies from myasthenia gravis sera","volume":"vol. 1131","author":"Tzartos","year":"2008"},{"key":"10.1016\/j.jneuroim.2008.06.020_bib46","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.jmb.2004.12.031","article-title":"Refined structure of the nicotinic acetylcholine receptor at 4A resolution","volume":"346","author":"Unwin","year":"2005","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jneuroim.2008.06.020_bib47","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nature01339","article-title":"Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation","volume":"421","author":"Wang","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2008.06.020_bib48","first-page":"318","article-title":"Efficiency and biocompatibility of a new immunosorbent","volume":"28","author":"Yamazaki","year":"1982","journal-title":"Trans Am Soc Artif. Intern. Organs"},{"key":"10.1016\/j.jneuroim.2008.06.020_bib49","unstructured":"Zisimopoulou, P., Lagoumintzis, G., Poulas, K., Tzartos, S., in press. Antigen-specific apheresis of human anti-acetylcholine receptor autoantibodies from myasthenia gravis patients' sera using Escherichia coli-expressed receptor domains. J Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2008.06.020_bib50","first-page":"13","article-title":"Distribution of cholinergic neurons in the mammalian brain with special reference to their relationship with neuronal nicotinic receptors","volume":"vol. 144","author":"Zoli","year":"2000"},{"key":"10.1016\/j.jneuroim.2008.06.020_bib51","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ijbiomac.2007.05.012","article-title":"Circular dichroism studies of extracellular domains of human nicotinic acetylcholine receptors provide an insight into their structure","volume":"41","author":"Zouridakis","year":"2007","journal-title":"Int. J. Biol. Macromol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572808002130?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572808002130?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:10:39Z","timestamp":1759047039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572808002130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":51,"alternative-id":["S0165572808002130"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2008.06.020","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Towards antigen-specific apheresis of pathogenic autoantibodies as a further step in the treatment of myasthenia gravis by plasmapheresis","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2008.06.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}